UNICA IRIS Institutional Research Information System

ZUDDAS, ALESSANDRO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 93.247
NA - Nord America 7.448
AS - Asia 1.047
OC - Oceania 29
SA - Sud America 15
Continente sconosciuto - Info sul continente non disponibili 3
AF - Africa 1
Totale 101.790
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 90.998
US - Stati Uniti d'America 7.389
UA - Ucraina 744
CN - Cina 656
SE - Svezia 486
GB - Regno Unito 298
DE - Germania 233
SG - Singapore 188
FI - Finlandia 187
FR - Francia 139
VN - Vietnam 81
CA - Canada 46
NL - Olanda 36
IN - India 35
AU - Australia 29
RU - Federazione Russa 26
HK - Hong Kong 22
CH - Svizzera 18
BE - Belgio 17
ES - Italia 14
IR - Iran 13
TR - Turchia 12
BR - Brasile 11
KR - Corea 10
IL - Israele 8
NO - Norvegia 8
RO - Romania 8
DK - Danimarca 7
JO - Giordania 6
CR - Costa Rica 5
IE - Irlanda 5
PT - Portogallo 5
MX - Messico 4
TW - Taiwan 4
AE - Emirati Arabi Uniti 3
EU - Europa 3
JP - Giappone 3
PK - Pakistan 3
PL - Polonia 3
AT - Austria 2
CL - Cile 2
CZ - Repubblica Ceca 2
DO - Repubblica Dominicana 2
EC - Ecuador 2
GR - Grecia 2
MT - Malta 2
SA - Arabia Saudita 2
SM - San Marino 2
AL - Albania 1
BD - Bangladesh 1
BZ - Belize 1
EE - Estonia 1
LV - Lettonia 1
MD - Moldavia 1
MU - Mauritius 1
PA - Panama 1
SI - Slovenia 1
Totale 101.790
Salva come PNG Salva come JPEG
Città #
Cagliari 84.603
Uta 4.200
Fairfield 921
Woodbridge 846
Chandler 596
Houston 568
Boardman 536
Ashburn 464
Ann Arbor 444
Jacksonville 390
Wilmington 384
Seattle 348
Nyköping 342
Cambridge 293
Milan 190
Rome 188
Boston 141
Nanjing 121
Dearborn 112
Beijing 91
Dong Ket 80
Singapore 78
Helsinki 71
Shanghai 63
San Diego 61
Redwood City 53
Shenyang 45
Padova 43
Charleston 40
Nanchang 38
Verona 35
Guangzhou 31
Turin 30
Bari 29
Changsha 27
Hebei 27
Sassari 27
Toronto 27
Jiaxing 26
Norwalk 25
New York 24
London 23
Los Angeles 23
Washington 22
Florence 20
Orange 20
Tianjin 20
Jinan 18
Pune 17
Auburn Hills 16
Ningbo 16
Naples 15
Palermo 15
Sydney 14
Zhengzhou 14
Falls Church 12
Genoa 12
Torino 12
Atlanta 11
Bologna 11
Brescia 11
Brussels 11
Catania 11
Messina 11
Mountain View 11
Parma 11
Saint Petersburg 11
Nuremberg 10
Redmond 10
Vicenza 10
Chicago 9
Kunming 9
Amsterdam 8
Frankfurt am Main 8
Las Vegas 8
Perugia 8
Stockholm 8
Venice 8
Busto Arsizio 7
Casale Monferrato 7
Castelverde 7
Faenza 7
Fidenza 7
Hangzhou 7
Montepulciano 7
Monza 7
Pescara 7
Pisa 7
Rimini 7
Taizhou 7
Venezia 7
Amman 6
Borås 6
Casavatore 6
Central 6
Livorno 6
Manchester 6
Mumbai 6
Phoenix 6
Sesto San Giovanni 6
Totale 97.287
Salva come PNG Salva come JPEG
Nome #
Child and Adolescent Behavior Inventory (CABI): Standardization for age 6-17 years and first clinical application 1.837
Prospective observational study protocol to investigate long-term adverse effects of methylphenidate in children and adolescents with ADHD: The Attention Deficit Hyperactivity Disorder Drugs Use Chronic Effects (ADDUCE) study 1.697
Systematic review of quality of life and functional outcomes in randomized placebo-controlled studies of medications for attention-deficit/hyperactivity disorder 1.666
Cognitive Function of Children and Adolescents with Attention-Deficit/Hyperactivity Disorder in a 2-Year Open-Label Study of Lisdexamfetamine Dimesylate 1.548
Practitioner Review: Current best practice in the use of parent training and other behavioural interventions in the treatment of children and adolescents with attention deficit hyperactivity disorder 1.479
Cardiovascular Effects of Stimulant and Non-Stimulant Medication for Children and Adolescents with ADHD: A Systematic Review and Meta-Analysis of Trials of Methylphenidate, Amphetamines and Atomoxetine 1.439
Neurological and psychiatric adverse effects of long-term methylphenidate treatment in ADHD: A map of the current evidence 1.423
Reports of Perceived Adverse Events of Stimulant Medication on Cognition, Motivation, and Mood: Qualitative Investigation and the Generation of Items for the Medication and Cognition Rating Scale 1.421
Comparative efficacy and tolerability of pharmacological interventions for attention-deficit/hyperactivity disorder in children, adolescents and adults: protocol for a systematic review and network meta-analysis 1.375
Cognitive training for attention-deficit/hyperactivity disorder: Meta-analysis of clinical and neuropsychological outcomes from randomized controlled trials 1.360
Supplementation with polyunsaturated fatty acids (PUFAs) in the management of attention deficit hyperactivity disorder (ADHD) 1.332
Development and psychometric properties of the Suicidality: Treatment Occurring in Paediatrics (STOP) Suicidality Assessment Scale (STOP-SAS) in children and adolescents 1.307
Unmet needs in paediatric psychopharmacology: Present scenario and future perspectives 1.297
Effects of methylphenidate on height in ADHD children. The monitoring of bone age within the ADDUCE project 1.259
The Italian autism network (ITAN): A resource for molecular genetics and biomarker investigations 1.241
Long-Term Safety and Efficacy of Lisdexamfetamine Dimesylate in Children and Adolescents with ADHD: A Phase IV, 2-Year, Open-Label Study in Europe 1.200
null 1.153
Growth and Puberty in a 2-Year Open-Label Study of Lisdexamfetamine Dimesylate in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder 1.147
ADHD and hyperkinetic disorder 1.113
Corrigendum: Child and adolescent behavior inventory (CABI): A new instrument for epidemiological studies and pre-clinical evaluation 1.099
ADHD management during the COVID-19 pandemic: guidance from the European ADHD Guidelines Group 1.085
Re-thinking treatment targets in child and adolescent psychiatry 1.082
Effects of long-term methylphenidate use on growth and blood pressure: Results of the German Health Interview and Examination Survey for Children and Adolescents (KiGGS) 1.070
null 1.045
null 980
Pediatric acute-onset neuropsychiatric syndrome: A data mining approach to a very specific constellation of clinical variables 967
Psychosocial risk factors for suicidality in children and adolescents 912
Methylphenidate long-term effects on psychiatric outcomes in a Sardinian ADHD population: preliminary results from the prospective ADDUCE project 876
null 754
A neurodevelopment approach for a transitional model of early onset schizophrenia 750
null 749
Long-acting methylphenidate formulations in the treatment of attention-deficit/hyperactivity disorder: a systematic review of head-to-head studies 730
Artificial neural networks analysis of polysomnographic and clinical features in pediatric acute-onset neuropsychiatric syndrome (Pans): From sleep alteration to “brain fog” 719
1H-NMR-Based Metabolomics in Autism Spectrum Disorder and Pediatric Acute-Onset Neuropsychiatric Syndrome 714
Erratum to: Long-acting methylphenidate formulations in the treatment of attention-deficit/hyperactivity disorder: A systematic review of head-to-head studies[ BMC Psychiatry. (2013)13, 237] 700
null 699
CRS-R. Conners’ Rating Scales. Revised. Manuale 697
null 688
null 675
null 665
null 658
Systematic Review and Meta-analysis: Screening Tools for Attention-Deficit/Hyperactivity Disorder in Children and Adolescents 653
Efficacy of lisdexamfetamine dimesylate throughout the day in children and adolescents with attention-deficit/hyperactivity disorder: results from a randomized, controlled trial 647
Prevalence and correlates of mental disorders among adolescents in Italy: The PrISMA Study 641
Metabolomic Characterization of Pediatric Acute-Onset Neuropsychiatric Syndrome (PANS) 638
null 632
null 603
null 595
Unbalanced risk-benefit analysis of ADHD drugs – Authors' reply 589
null 588
null 581
null 581
null 568
null 564
null 549
The poor outcome of conduct disorders: a need for innovative, more effective therapeutic interventions 538
null 536
null 519
null 517
Neuropsychological characterization of aggressive behavior in children and adolescents with cd/odd and effects of single doses of medications: The protocol of the matrics_wp6-1 study 517
The management of ADHD in children and adolescents: bringing evidence to the clinic: perspective from the European ADHD Guidelines Group (EAGG) 508
Long term methylphenidate exposure and growth in children and adolescents with ADHD. A systematic review and meta-analysis 507
null 506
Identifying Neurobiological Markers in Obsessive–Compulsive Disorder: A Study Protocol for a Cross-Sectional Study in Subgroups of Differing Phenotype 504
null 501
null 501
The pharmacological treatment of aggression in children and adolescents with conduct disorder. Do callous-unemotional traits modulate the efficacy of medication? 501
null 497
Post hoc analyses of the impact of previous medication on the efficacy of lisdexamfetamine dimesylate in the treatment of attention-deficit/hyperactivity disorder in a randomized, controlled trial 497
Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis 494
null 491
null 477
Increased Response-Time Variability Across Different Cognitive Tasks in Children With ADHD 470
I Disturbi depressivi in età evolutiva 469
Vortioxetine for Major Depressive Disorder in Adolescents: 12-Week Randomized, Placebo-Controlled, Fluoxetine-Referenced, Fixed-Dose Study 469
null 467
Profili cognitivi e disturbi psicopatologici. Evidenze neurobiologiche, diagnosi, trattamento 464
A crucial role for basic emotion awareness in the development of emotion regulation? 457
Omega-3/6 supplementation for mild to moderate inattentive ADHD: a randomised, double-blind, placebo-controlled efficacy study in Italian children 453
null 444
Methylphenidate effects on height and bone age in ADHD children. 24 month follow up within the prospective ADDUCE project 440
A post hoc comparison of the effects of lisdexamfetamine dimesylate and osmotic-release oral system methylphenidate on symptoms of attention-deficit hyperactivity disorder in children and adolescents 436
null 428
Eziologia 426
Use of atomoxetine in patients with attention-deficit hyperactivity disorder and comorbid conditions 422
Clinical characteristics, neuroimaging findings, and neuropsychological functioning in attention-deficit hyperactivity disorder: Sex differences 418
The MTA at 8 416
Association of Risk of Suicide Attempts With Methylphenidate Treatment 411
null 400
null 399
The neuropsychological characterization of aggressive behaviour in children and adolescents with CD/ODD: preliminary results from a multicentric case-control study (MATRICS_consortium) 399
Maintenance of efficacy of lisdexamfetamine dimesylate in children and adolescents with attention-deficit/hyperactivity disorder: randomized-withdrawal study design 390
Management and treatment of attention-deficit/hyperactivity disorder 382
null 379
null 378
European clinical guidelines for hyperkinetic disorder - first upgrade 369
EFFICACY STUDY OF AN OMEGA-3/6 COMBINATION FOR MILD- TO MODERATE-INATTENTIVE ADHD: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL IN ITALIAN CHILDREN 367
The quality of life of children with attention deficit/hyperactivity disorder: a systematic review 364
Non-pharmacological interventions for Attention-Deficit/Hyperactivity Disorder: Systematic review and meta-analyses of randomised controlled trials of dietary and psychological treatments 358
null 355
Totale 73.278
Salva come PNG Salva come JPEG
Categoria #
all - tutte 141.112
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 141.112
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202010.695 0 0 0 501 3.549 2.340 1.909 538 444 340 479 595
2020/202116.858 777 510 925 3.862 3.262 1.867 1.869 953 511 590 483 1.249
2021/20227.717 573 518 324 892 763 432 371 602 813 872 740 817
2022/202314.642 1.096 1.876 1.615 1.119 1.080 1.161 683 1.973 984 874 1.515 666
2023/202417.145 834 685 636 1.068 1.981 2.656 2.826 1.023 853 1.235 1.807 1.541
2024/202521.042 5.788 8.957 5.420 877 0 0 0 0 0 0 0 0
Totale 102.257